Diphosphonates inhibit formation of calcium phosphate crystals in vitro and pathological calcification in vivo.
Two diphosphonates containing the P-C-P bond, CH(3)C(OH)(PO(3)HNa)(2) and H(2)C(PO(3)HNa)(2), inhibit the crystallization of calcium phosphate in vitro and prevent aortic calcification of rats given large amounts of vitamin D(3). The diphosphonates therefore have effects similar to those described for compounds containing the P-O-P bond but are active when administered orally.
D000818:Animals; D001018:Aortic Diseases / Q000139:chemically induced*; D002114:Calcinosis / Q000139:chemically induced / Q000517:prevention & control*; D002762:Cholecalciferol / Q000494:pharmacology; D003460:Crystallization; D011756:Diphosphates / Q000494:pharmacology; D006863:Hydrogen-Ion Concentration; D063065:Organophosphonates / Q000008:administration & dosage*; D010710:Phosphates / Q000037:antagonists & inhibitors; D051381:Rats; D014961:X-Ray Diffraction
D011756:Diphosphates; D063065:Organophosphonates; D010710:Phosphates; D002762:Cholecalciferol